{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:10:22Z","timestamp":1786119022549,"version":"build-2736575974"},"reference-count":22,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1097\/inf.0b013e31817eeee5","type":"journal-article","created":{"date-parts":[[2008,11,25]],"date-time":"2008-11-25T03:11:59Z","timestamp":1227582719000},"page":"1083-1088","source":"Crossref","is-referenced-by-count":48,"title":["Pediatric Antifungal Utilization"],"prefix":"10.1097","volume":"27","author":[{"given":"Priya A.","family":"Prasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan E.","family":"Coffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kateri H.","family":"Leckerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theoklis E.","family":"Zaoutis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-8-20210202","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.idc.2006.06.006","article-title":"Mycoses in pediatric patients.","volume":"20","author":"Steinbach","year":"2006","journal-title":"Infect Dis Clin North Am"},{"key":"R2-8-20210202","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1038\/sj.bmt.1705113","article-title":"Risks and outcomes of invasive fungal infections in pediatric patients undergoing allogeneic hematopoietic cell transplantation.","volume":"36","author":"Dvorak","year":"2005","journal-title":"Bone Marrow Transplant"},{"key":"R3-8-20210202","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1086\/496922","article-title":"The epidemiology and attributable outcomes of candidemia in adults and children hospitalized in the United States: a propensity analysis.","volume":"41","author":"Zaoutis","year":"2005","journal-title":"Clin Infect Dis"},{"key":"R4-8-20210202","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1097\/01.inf.0000172938.76561.8e","article-title":"Risk factors for mortality in children with candidemia.","volume":"24","author":"Zaoutis","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R5-8-20210202","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1086\/513196","article-title":"Outcomes attributable to neonatal candidiasis.","volume":"44","author":"Zaoutis","year":"2007","journal-title":"Clin Infect Dis"},{"key":"R6-8-20210202","doi-asserted-by":"crossref","first-page":"e711","DOI":"10.1542\/peds.2005-1161","article-title":"Epidemiology, outcomes, and costs of invasive aspergillosis in immunocompromised children in the United States, 2000.","volume":"117","author":"Zaoutis","year":"2006","journal-title":"Pediatrics"},{"key":"R7-8-20210202","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1542\/peds.2004-2292","article-title":"Neonatal candidiasis among extremely low birth weight infants: risk factors, mortality rates, and neurodevelopmental outcomes at 18 to 22 months.","volume":"117","author":"Benjamin","year":"2006","journal-title":"Pediatrics"},{"key":"R8-8-20210202","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00006454-200004000-00011","article-title":"Risk factors for candidemia in Neonatal Intensive Care Unit patients. The National Epidemiology of Mycosis Survey study group.","volume":"19","author":"Saiman","year":"2000","journal-title":"Pediatr Infect Dis J"},{"key":"R9-8-20210202","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/01.inf.0000253973.89097.c0","article-title":"Excess costs of hospital care associated with neonatal candidemia.","volume":"26","author":"Smith","year":"2007","journal-title":"Pediatr Infect Dis J"},{"key":"R10-8-20210202","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1097\/01.inf.0000157218.37603.84","article-title":"Pediatric aspergillosis: disease and treatment differences in children.","volume":"24","author":"Steinbach","year":"2005","journal-title":"Pediatr Infect Dis J"},{"key":"R11-8-20210202","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1097\/01.mop.0000150630.83442.e1","article-title":"New agents for invasive mycoses in children.","volume":"17","author":"Antachopoulos","year":"2005","journal-title":"Curr Opin Pediatr"},{"key":"R12-8-20210202","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1542\/peds.2006-2931","article-title":"Antifungal therapy in children with invasive fungal infections: a systematic review.","volume":"119","author":"Blyth","year":"2007","journal-title":"Pediatrics"},{"key":"R13-8-20210202","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1097\/01.qco.0000185986.64759.9a","article-title":"New antifungal agents under development in children and neonates.","volume":"18","author":"Steinbach","year":"2005","journal-title":"Curr Opin Infect Dis"},{"key":"R14-8-20210202","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.drup.2005.06.005","article-title":"Antifungal treatment in pediatric patients.","volume":"8","author":"Zaoutis","year":"2005","journal-title":"Drug Resist Updat"},{"key":"R15-8-20210202","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1001\/jama.297.24.2725","article-title":"Shifting place of death among children with complex chronic conditions in the United States, 1989\u20132003.","volume":"297","author":"Feudtner","year":"2007","journal-title":"JAMA"},{"key":"R16-8-20210202","doi-asserted-by":"crossref","first-page":"E99","DOI":"10.1542\/peds.107.6.e99","article-title":"Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services.","volume":"107","author":"Feudtner","year":"2001","journal-title":"Pediatrics"},{"key":"R18-8-20210202","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1056\/NEJMoa065733","article-title":"A multicenter, randomized trial of prophylactic fluconazole in preterm neonates.","volume":"356","author":"Manzoni","year":"2007","journal-title":"N Engl J Med"},{"key":"R19-8-20210202","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1056\/NEJMoa010494","article-title":"Fluconazole prophylaxis against fungal colonization and infection in preterm infants.","volume":"345","author":"Parikh","year":"2001","journal-title":"N Engl J Med"},{"key":"R20-8-20210202","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis.","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"R22-8-20210202","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1128\/AAC.49.11.4536-4545.2005","article-title":"Pharmacokinetics, safety, and tolerability of caspofungin in children and adolescents.","volume":"49","author":"Walsh","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"R24-8-20210202","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1056\/NEJMoa020191","article-title":"Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis.","volume":"347","author":"Herbrecht","year":"2002","journal-title":"N Engl J Med"},{"key":"R25-8-20210202","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1128\/AAC.48.6.2166-2172.2004","article-title":"Pharmacokinetics and safety of intravenous voriconazole in children after single- or multiple-dose administration.","volume":"48","author":"Walsh","year":"2004","journal-title":"Antimicrob Agents Chemother"}],"container-title":["Pediatric Infectious Disease Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006454-200812000-00008","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:24:15Z","timestamp":1786037055000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006454-200812000-00008"}},"subtitle":["New Drugs, New Trends"],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/inf.0b013e31817eeee5","relation":{},"ISSN":["0891-3668"],"issn-type":[{"value":"0891-3668","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]}}}